Key result
Under the new diagnostic criterion of >5.0 mmol/L, the incidence of hyperkalemia in maintenance hemodialysis patients was 38.81%, significantly higher than the 19.67% seen with the old criterion.
Why the study?
The threshold defining hyperkalemia in maintenance hemodialysis patients was lowered from 5.5 mmol/L to 5.0 mmol/L, requiring clarification of incidence and risk factors under this criterion.
What is the incidence of hyperkalemia and its associated risk factors in patients on maintenance hemodialysis under the new diagnostic criterion of >5.0 mmol/L?
Cross-Sectional (n=2,582)
Yes
What is the incidence of hyperkalemia and its associated risk factors in patients on maintenance hemodialysis under the new diagnostic criterion of >5.0 mmol/L?
The incidence of hyperkalemia in maintenance hemodialysis patients is high (38.81%) under the new >5.0 mmol/L criterion, with ACEI/ARB use, higher systolic blood pressure, and lower residual urine volume identified as independent risk factors.
Answers are grounded in this paper and cite their sources.
Updated hyperkalemia incidence data in hemodialysis may prompt closer monitoring; leaves open optimal prevention thresholds pending prospective studies.
Objective: For patients on maintenance hemodialysis, hyperkalemia has now been lowered from 5.5 mmol/L to 5.0 mmol/L. We undertook this study in order to clarify the incidence of hyperkalemia under this new criterion, to determine the associated risk factors, and to provide guidance for the prevention of hyperkalemia. Methods: Data from all hemodialysis centers of Foshan City were included in a crosssectional survey, the overall incidence of hyperkalemia was determined and the risk factors were analyzed. Results: Our study comprised 2582 patients from 34 dialysis centers. 107 patients (4.14%) with serum potassium levels at or below 3.5 mmol/L, 1473(57.05%) with serum potassium levels between 3.5 and 5.0 mmol/L, 494 (19.13%) with serum potassium levels between 5.0 and 5.5 mmol/L, and 508 (19.67%) with serum potassium levels above 5.5 mmol/L. The Incidence of hyperkalemia was significantly greater under the new criterion than the old criterion (38.81% vs 19.67%, P <0.001). We divided the patients into non-hyperkalemia and hyperkalemia groups by the new criterion. Patients in the hyperkalemia group were younger, higher body-mass indices (BMIs), higher systolic and diastolic blood pressures, higher serum creatinine, higher serum blood urea nitrogen (BUN), lower pre-dialysis carbon dioxide combining power (CO2CP), and less residual urine volume(RUV), higher proportion of using angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs). Through multiple logistic regression analysis, we found that systolic blood pressure, RUV, ACEI/ARB usage, pre-dialysis CO2CP, and pre-dialysis BUN were independent risk factors for hyperkalemia. Conclusion: In the Foshan area, the incidence of hyperkalemia in patients on maintenance hemodialysis is very high. Under the new criterion, the diagnosis rate of hyperkalemia would be significantly increased. Moreover, high systolic blood pressure,decreased RUV, decreased pre-dialysis CO2CP, increased pre-dialysis BUN, and the use of ACEIs/ARBs were found to be independent risk factors for hyperkalemia.
No takes yet. Share an insight, caveat, or question.
Xie et al. (2023) conducted a cross-sectional in Maintenance hemodialysis (n=2,582). New diagnostic criterion (>5.0 mmol/L) vs. Old diagnostic criterion (>5.5 mmol/L) was evaluated on Incidence of hyperkalemia (p=<0.001). Under the new diagnostic criterion of >5.0 mmol/L, the incidence of hyperkalemia in maintenance hemodialysis patients was 38.81%, significantly higher than the 19.67% seen with the old criterion.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: